Categories: News

SignatureMD Completes Merger with Cypress Membership Medicine

SANTA MONICA, CA / ACCESSWIRE / March 31, 2021 / SignatureMD, Inc. (“SignatureMD”) and Cypress Membership Medicine, LLC (“Cypress”), two leading providers in membership-based concierge medicine (collectively, the “Company”), have merged in partnership with management and Blue Sea Capital LLC (“Blue Sea”). The partnership with Cypress cements SignatureMD’s position as one of nation’s largest providers of initial conversion and ongoing support services to concierge medicine physicians, with an expanding network of over 200 affiliated primary care physicians and specialists across 35 states.

“We are proud to merge with Cypress as they share our core values to always do the right thing for our affiliated physicians and members and to provide them with the highest level of service and care,” said Matthew Jacobson, Founder and Chief Executive Officer of SignatureMD. “Combining our two companies is about getting better and stronger together to expand our community of exceptional physicians, to serve more people looking for a closer relationship with their doctor for better health and peace of mind, and to innovate in areas like remote monitoring to meet the emerging needs of our affiliated physicians and members. This merger comes at an exciting time as more and more doctors are choosing SignatureMD’s flexible care model that puts them back in control without having to decide between practicing medicine on their terms and saying good-bye to thousands of their patients.”

“The merger allows us to better capitalize on the substantial sector growth opportunity while maintaining a high-quality service offering to our existing affiliated physicians and members,” said Julie Robinson, CEO of Cypress. “I have always had great respect for SignatureMD, and I am excited about what we can accomplish together to improve the lives of more people with the Company’s combined resources and capabilities.”

Scott Ames, Principal at Blue Sea, commented, “The merger of SignatureMD and Cypress brings together two industry-leading concierge medicine platforms, and we are excited to support the combination. We look forward to building on the companies’ track records of providing best-in-class services to affiliated physicians and members, while capitalizing on a sector that remains well-positioned for long-term growth driven by a superior value proposition and certainty to providers and members alike.”

CapM Advisors acted as financial advisor to SignatureMD. McDermott Will & Emery served as legal advisor to SignatureMD and Phelps Dunbar LLP served as legal advisor to Cypress.

About the Company

The Company, operating under the SignatureMD (www.signaturemd.com) and Cypress Membership Medicine (www.yourcypress.com) brands, with offices in Los Angeles, California and Franklin, Tennessee, is one of the nation’s largest providers of initial conversion and ongoing support services to concierge medicine physicians, with an expanding network of over 200 affiliated primary care physicians and specialists across 35 states.

About Blue Sea Capital

Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida that invests in growth-oriented lower middle market companies valued up to $250 million. The firm has over $750 million in assets under management and invests across three industry verticals: aerospace & defense, healthcare and industrial growth. Blue Sea Capital’s strategy is to partner with talented managers and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration and business transformation.

CONTACT: 
Matthew Jacobson
310-299-7797

SOURCE: SignatureMD

View source version on accesswire.com:
https://www.accesswire.com/638284/SignatureMD-Completes-Merger-with-Cypress-Membership-Medicine

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

7 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

7 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago